Heterologous Expression, Purification, and Functional Analysis of the Plasmodium falciparum Phosphatidylinositol 4-Kinase IIIβ

Biochemistry ◽  
2020 ◽  
Vol 59 (27) ◽  
pp. 2494-2506 ◽  
Author(s):  
Anna R. Sternberg ◽  
Paul D. Roepe
Biochemistry ◽  
2017 ◽  
Vol 56 (33) ◽  
pp. 4335-4345 ◽  
Author(s):  
Matthew R. Hassett ◽  
Anna R. Sternberg ◽  
Bryce E. Riegel ◽  
Craig J. Thomas ◽  
Paul D. Roepe

2018 ◽  
Vol 62 (4) ◽  
Author(s):  
Suvitha Subramaniam ◽  
Christoph D. Schmid ◽  
Xue Li Guan ◽  
Pascal Mäser

ABSTRACT Combinatorial chemotherapy is necessary for the treatment of malaria. However, finding a suitable partner drug for a new candidate is challenging. Here we develop an algorithm that identifies all of the gene pairs of Plasmodium falciparum that possess orthologues in yeast that have a synthetic lethal interaction but are absent in humans. This suggests new options for drug combinations, particularly for inhibitors of targets such as P. falciparum calcineurin, cation ATPase 4, or phosphatidylinositol 4-kinase.


2009 ◽  
Vol 39 (6) ◽  
pp. 645-653 ◽  
Author(s):  
Werner Leber ◽  
Alison Skippen ◽  
Quinton L. Fivelman ◽  
Paul W. Bowyer ◽  
Shamshad Cockcroft ◽  
...  

2006 ◽  
Vol 148 (2) ◽  
pp. 144-160 ◽  
Author(s):  
Christopher Mehlin ◽  
Erica Boni ◽  
Frederick S. Buckner ◽  
Linnea Engel ◽  
Tiffany Feist ◽  
...  

2012 ◽  
Vol 56 (5) ◽  
pp. 2283-2289 ◽  
Author(s):  
Rowena E. Martin ◽  
Alice S. Butterworth ◽  
Donald L. Gardiner ◽  
Kiaran Kirk ◽  
James S. McCarthy ◽  
...  

ABSTRACTThe antiretroviral protease inhibitors (APIs) ritonavir, saquinavir, and lopinavir, used to treat HIV infection, inhibit the growth ofPlasmodium falciparumat clinically relevant concentrations. Moreover, it has been reported that these APIs potentiate the activity of chloroquine (CQ) against this parasitein vitro. The mechanism underlying this effect is not understood, but the degree of chemosensitization varies between the different APIs and, with the exception of ritonavir, appears to be dependent on the parasite exhibiting a CQ-resistant phenotype. Here we report a study of the role of theP. falciparumchloroquine resistance transporter (PfCRT) in the interaction between CQ and APIs, using transgenic parasites expressing different PfCRT alleles and using theXenopus laevisoocyte system for the heterologous expression of PfCRT. Our data demonstrate that saquinavir behaves as a CQ resistance reverser and that this explains, at least in part, its ability to enhance the effects of CQ in CQ-resistantP. falciparumparasites.


2013 ◽  
Vol 20 (11) ◽  
pp. 1204-1210 ◽  
Author(s):  
João Alves Filho ◽  
Antonia Fernandes do Nascimento ◽  
Ana Silva Gondim ◽  
Ronniery Pereira ◽  
Rodrigo Silva da Cunha ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document